Inventor · disambiguated record
John A. Galloway
Also filed as: GALLOWAY JOHN · GALLOWAY JOHN A
10 granted patents·1 pending application·855 citations·filing 1984–2024
94Inventor score
Top patents by PatentIndex Score
11 records- 0198US6388053B1Glucagon-like insulinotropic peptides, compositions and methodsLILLY CO ELI·Filed 2001·Granted May 14, 2002·111 cites·13 claims
- 0298US5705483AGlucagon-like insulinotropic peptides, compositions and methodsLILLY CO ELI·Filed 1995·Granted Jan 6, 1998·246 cites·4 claims
- 0396US6703365B2Glucagon-like insulinotropic peptides, compositions and methodsLILLY CO ELI·Filed 2002·Granted Mar 9, 2004·71 cites·6 claims
- 0496US5977071AGlucagon-like insulinotropic peptides, compositions and methodsLILLY CO ELI·Filed 1997·Granted Nov 2, 1999·134 cites·34 claims
- 0595US6133235AGlucagon-like insulinotropic peptides compositions and methodsLILLY CO ELI·Filed 1999·Granted Oct 17, 2000·106 cites·9 claims
- 0694US6410513B1Glucagon-like insulinotropic peptides, compositions and methodsLILLY CO ELI·Filed 2000·Granted Jun 25, 2002·83 cites·12 claims
- 0791US7232879B2Glucagon-like insulinotropic peptides, compositions and methodsLILLY CO ELI·Filed 2004·Granted Jun 19, 2007·28 cites·1 claims
- 0873US4654324AHuman proinsulin pharmaceutical formulationsLILLY CO ELI·Filed 1984·Granted Mar 31, 1987·31 cites·3 claims
- 0973US4652548APharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulinLILLY CO ELI·Filed 1984·Granted Mar 24, 1987·32 cites·17 claims
- 1059US2025092078A1Compounds for activating invariant natural killer t-cells and methods of use in eliminating inflammatory senescent cellsDECIDUOUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1154US4652547APharmaceutical formulations comprising human insulin and human proinsulinLILLY CO ELI·Filed 1984·Granted Mar 24, 1987·13 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →